BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17720637)

  • 1. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Archimandritis AJ
    Dig Liver Dis; 2007 Oct; 39(10):936-42. PubMed ID: 17720637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Petraki K; Hadziyannis E; Pandelidaki H; Zafiropoulou R; Savvas S; Koskinas J; Archimandritis AJ
    Am J Gastroenterol; 2007 Mar; 102(3):634-41. PubMed ID: 17222326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
    Peng D; Han Y; Ding H; Wei L
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
    Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
    J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.
    Matos CA; Perez RM; Pacheco MS; Figueiredo-Mendes CG; Lopes-Neto E; Oliveira EB; Lanzoni VP; Silva AE; Ferraz ML
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1236-9. PubMed ID: 16872303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B].
    Shi JP; Fan JG; Wu R; Gao XQ; Zhang L; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):519-23. PubMed ID: 18647531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
    Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
    Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
    Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatic steatosis in chronic hepatitis B patients and its association with disease severity.
    Lesmana LA; Lesmana CR; Pakasi LS; Krisnuhoni E
    Acta Med Indones; 2012 Jan; 44(1):35-9. PubMed ID: 22451183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
    Castéra L; Loko MA; Le Bail B; Coffie P; De Ledinghen V; Trimoulet P; Winnock M; Dabis F; Neau D;
    Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1489-98. PubMed ID: 17903235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China.
    You J; Sriplung H; Chongsuvivatwong V; Geater A; Zhuang L; Huang JH; Chen HY; Yu L; Tang BZ
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):271-9. PubMed ID: 18522881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
    Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic steatosis in chronic hepatitis B: contributing factors and effect on fibrosis.
    Elloumi H; Hefaiedh R; Gargouri D; Chedly-Debbiche A; Khayat O; Bel Hadj N; Kharrat J; Ghorbel A
    Tunis Med; 2008 Nov; 86(11):1000-3. PubMed ID: 19213493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steatosis correlates with hepatic expression of death receptors and activation of nuclear factor-kappaB in chronic hepatitis C.
    Hung CH; Lee CM; Kuo FY; Jiang SR; Hu TH; Chen CH; Wang JH; Lu SN; Eng HL; Changchien CS
    Liver Int; 2008 Mar; 28(3):339-46. PubMed ID: 18290776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters.
    Rastogi A; Sakhuja P; Kumar A; Hissar S; Jain A; Gondal R; Sarin SK
    Indian J Pathol Microbiol; 2011; 54(3):454-9. PubMed ID: 21934202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
    Marks KM; Petrovic LM; Talal AH; Murray MP; Gulick RM; Glesby MJ
    J Infect Dis; 2005 Dec; 192(11):1943-9. PubMed ID: 16267765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.
    Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK
    J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis is uncommon in children with chronic hepatitis B.
    Giannattasio A; Cirillo F; Terlizzi V; Liccardo D; Vecchione R; Iorio R
    J Clin Virol; 2009 Dec; 46(4):360-2. PubMed ID: 19828370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
    Liu CJ; Jeng YM; Chen PJ; Lai MY; Yang HC; Huang WL; Kao JH; Chen DS
    Antivir Ther; 2005; 10(3):405-15. PubMed ID: 15918331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.